New pill hopes to clear stubborn hand and foot blisters
NCT ID NCT07270003
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a daily pill called ivarmacitinib for palmoplantar pustulosis (PPP), a chronic skin condition causing painful blisters on hands and feet. Sixty adults who haven't improved with other treatments will take the pill for 12 weeks. Researchers will check if symptoms like blisters and redness get at least 50% better, and track any side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ivarmacitinib
- What this could lead to
- If it works, this could offer a new oral treatment option for people with palmoplantar pustulosis who haven't responded to other therapies.
- What could go wrong
- This is a small, early-stage trial with no control group, so results may not be conclusive. Side effects like infections or stomach issues are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PALMOPLANTAR PUSTULOSIS (PPP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xijing hospital
RECRUITINGXi'an, Shaanxi, 710000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.